ISSN: 2165-8056
Fang Cao
Department of Pathology
University of Michigan, USA
Dr. Cao received her PhD degree from Shanghai Institute of Biochemistry, CAS in 2006. Her PhD research work is mainly on the molecular mechanisms of morphogenesis and pathogenesis of Candida albicans. She then started her postdoctoral training in the University of Michigan Since 2007. Dr. Cao has completed one grant from National Natural Science Foundation of China as principal investigator. She is currently playing a critical role in SU2C grant ‘Targeting MLL in acute leukemia. Dr. Cao holds one issued China patent and one pending US patent. She regularly reviews manuscripts for PLOS ONE and Journal of Cancer therapy.
Dr. Cao received her PhD degree from Shanghai Institute of Biochemistry, CAS in 2006. Her PhD research work is mainly on the molecular mechanisms of morphogenesis and pathogenesis of Candida albicans. She then started her postdoctoral training in the University of Michigan Since 2007. Dr. Cao has completed one grant from National Natural Science Foundation of China as principal investigator. She is currently playing a critical role in SU2C grant ‘Targeting MLL in acute leukemia. Dr. Cao holds one issued China patent and one pending US patent. She regularly reviews manuscripts for PLOS ONE and Journal of Cancer therapy.